U.S. investors have tried for the past few years to access the growth in the Israeli market without a true index vehicle for doing so. The Amidex35 is probably the most accurate vehicle for those looking to get exposure to Israel as a whole. It’s an interesting index, splitting total market cap between Tel Aviv and the U.S (around 60/40). So, you get local Israel exposure with some growth-y tech companies layered in. Kudos to Amidex’s Cliff Goldstein who shared some time with us on CNBC recently talking about Israeli companies and the market opportunity as a whole. We interviewed Cliff a couple of months ago and it’s worth reading that interview again here. (Continue »)

Share with others: